

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.70863792 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.71063375 |
| 3 | * skeletal muscle contraction (GO:0003009) | 8.00403254 |
| 4 | myofibril assembly (GO:0030239) | 7.97373830 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.80571335 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.21847559 |
| 7 | muscle filament sliding (GO:0030049) | 7.21847559 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.13383133 |
| 9 | plasma membrane repair (GO:0001778) | 6.85703898 |
| 10 | cardiac muscle contraction (GO:0060048) | 6.83730074 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.83478462 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.60008632 |
| 13 | cardiac muscle cell development (GO:0055013) | 6.46226067 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.37781966 |
| 15 | tricarboxylic acid cycle (GO:0006099) | 6.29635936 |
| 16 | regulation of actin filament-based movement (GO:1903115) | 6.25574469 |
| 17 | cardiac cell development (GO:0055006) | 6.07083473 |
| 18 | actomyosin structure organization (GO:0031032) | 5.99121297 |
| 19 | adult heart development (GO:0007512) | 5.98958375 |
| 20 | response to muscle activity (GO:0014850) | 5.95293155 |
| 21 | regulation of skeletal muscle contraction (GO:0014819) | 5.94440282 |
| 22 | actin-mediated cell contraction (GO:0070252) | 5.93471424 |
| 23 | regulation of relaxation of muscle (GO:1901077) | 5.91667162 |
| 24 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.82742602 |
| 25 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.81432097 |
| 26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.78647908 |
| 27 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.76288596 |
| 28 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.75548379 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.65189223 |
| 30 | cardiac muscle hypertrophy (GO:0003300) | 5.36901491 |
| 31 | * striated muscle contraction (GO:0006941) | 5.19472691 |
| 32 | carnitine shuttle (GO:0006853) | 5.18519577 |
| 33 | muscle tissue morphogenesis (GO:0060415) | 5.17691681 |
| 34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.17631611 |
| 35 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.15854144 |
| 36 | heart trabecula formation (GO:0060347) | 5.14590900 |
| 37 | striated muscle hypertrophy (GO:0014897) | 5.10513578 |
| 38 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.04301981 |
| 39 | regulation of sarcomere organization (GO:0060297) | 5.01654033 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 5.00377383 |
| 41 | skeletal muscle fiber development (GO:0048741) | 4.99720826 |
| 42 | * muscle system process (GO:0003012) | 4.95439237 |
| 43 | regulation of cell communication by electrical coupling (GO:0010649) | 4.90641640 |
| 44 | heart process (GO:0003015) | 4.88982790 |
| 45 | heart contraction (GO:0060047) | 4.88982790 |
| 46 | skeletal muscle adaptation (GO:0043501) | 4.88834965 |
| 47 | regulation of the force of heart contraction (GO:0002026) | 4.84114997 |
| 48 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.71472401 |
| 49 | cell communication involved in cardiac conduction (GO:0086065) | 4.67143834 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.66405465 |
| 51 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.55978818 |
| 52 | myotube cell development (GO:0014904) | 4.55733600 |
| 53 | striated muscle adaptation (GO:0014888) | 4.55250523 |
| 54 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.53280283 |
| 55 | muscle hypertrophy (GO:0014896) | 4.51606924 |
| 56 | glycogen catabolic process (GO:0005980) | 4.50394636 |
| 57 | actin filament-based movement (GO:0030048) | 4.48064537 |
| 58 | fatty acid transmembrane transport (GO:1902001) | 4.43863747 |
| 59 | muscle fiber development (GO:0048747) | 4.36596790 |
| 60 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.30171452 |
| 61 | regulation of cofactor metabolic process (GO:0051193) | 4.27844075 |
| 62 | regulation of coenzyme metabolic process (GO:0051196) | 4.27844075 |
| 63 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.23223958 |
| 64 | glucan catabolic process (GO:0009251) | 4.23080855 |
| 65 | glucan biosynthetic process (GO:0009250) | 4.20632476 |
| 66 | glycogen biosynthetic process (GO:0005978) | 4.20632476 |
| 67 | creatine metabolic process (GO:0006600) | 4.18805425 |
| 68 | regulation of cardiac muscle contraction (GO:0055117) | 4.16060733 |
| 69 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.09534127 |
| 70 | regulation of heart rate (GO:0002027) | 4.07742507 |
| 71 | NADH metabolic process (GO:0006734) | 4.05469189 |
| 72 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.02761586 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 4.00715940 |
| 74 | negative regulation of protein localization to cell surface (GO:2000009) | 3.99719143 |
| 75 | regulation of ATPase activity (GO:0043462) | 3.99527552 |
| 76 | regulation of ATP catabolic process (GO:1903289) | 3.99527552 |
| 77 | skeletal muscle tissue development (GO:0007519) | 3.97877445 |
| 78 | cellular polysaccharide catabolic process (GO:0044247) | 3.96523641 |
| 79 | cardiac muscle cell action potential (GO:0086001) | 3.96479220 |
| 80 | negative regulation of potassium ion transport (GO:0043267) | 3.96143593 |
| 81 | ATP synthesis coupled proton transport (GO:0015986) | 3.94947974 |
| 82 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.94947974 |
| 83 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.94145779 |
| 84 | cell communication by electrical coupling (GO:0010644) | 3.90869399 |
| 85 | cardiac muscle adaptation (GO:0014887) | 3.84595718 |
| 86 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.84595718 |
| 87 | muscle hypertrophy in response to stress (GO:0003299) | 3.84595718 |
| 88 | carnitine transmembrane transport (GO:1902603) | 3.84357318 |
| 89 | regulation of sequestering of triglyceride (GO:0010889) | 3.82350781 |
| 90 | regulation of heart contraction (GO:0008016) | 3.81420551 |
| 91 | respiratory electron transport chain (GO:0022904) | 3.78303245 |
| 92 | positive regulation of heart rate (GO:0010460) | 3.72467410 |
| 93 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.72386275 |
| 94 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.72386275 |
| 95 | muscle adaptation (GO:0043500) | 3.70455799 |
| 96 | relaxation of cardiac muscle (GO:0055119) | 3.69209196 |
| 97 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.68312528 |
| 98 | striated muscle cell development (GO:0055002) | 3.67328562 |
| 99 | electron transport chain (GO:0022900) | 3.66545996 |
| 100 | muscle cell cellular homeostasis (GO:0046716) | 3.66316301 |
| 101 | positive regulation of cation channel activity (GO:2001259) | 3.64463852 |
| 102 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.64240519 |
| 103 | regulation of cardioblast differentiation (GO:0051890) | 3.63573656 |
| 104 | positive regulation of heart contraction (GO:0045823) | 3.62076062 |
| 105 | response to inactivity (GO:0014854) | 3.59376686 |
| 106 | oxidative phosphorylation (GO:0006119) | 3.56605725 |
| 107 | polysaccharide catabolic process (GO:0000272) | 3.56352061 |
| 108 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.51349219 |
| 109 | * muscle contraction (GO:0006936) | 3.51132369 |
| 110 | carnitine transport (GO:0015879) | 3.49854347 |
| 111 | amino-acid betaine transport (GO:0015838) | 3.49854347 |
| 112 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48948517 |
| 113 | regulation of sulfur metabolic process (GO:0042762) | 3.48750642 |
| 114 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.45777883 |
| 115 | regulation of muscle system process (GO:0090257) | 3.45415395 |
| 116 | cardiac conduction (GO:0061337) | 3.44485526 |
| 117 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.43289853 |
| 118 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.43289853 |
| 119 | skeletal muscle tissue regeneration (GO:0043403) | 3.43072116 |
| 120 | glycogen metabolic process (GO:0005977) | 3.39435697 |
| 121 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.38824521 |
| 122 | striated muscle atrophy (GO:0014891) | 3.38578368 |
| 123 | ventricular cardiac muscle cell development (GO:0055015) | 3.36722011 |
| 124 | gluconeogenesis (GO:0006094) | 3.34486329 |
| 125 | aspartate family amino acid catabolic process (GO:0009068) | 3.34331993 |
| 126 | regulation of fatty acid oxidation (GO:0046320) | 3.33825146 |
| 127 | regulation of muscle contraction (GO:0006937) | 3.32931696 |
| 128 | muscle cell fate commitment (GO:0042693) | 3.32877912 |
| 129 | glucan metabolic process (GO:0044042) | 3.32635649 |
| 130 | cellular glucan metabolic process (GO:0006073) | 3.32635649 |
| 131 | muscle organ development (GO:0007517) | 3.32025718 |
| 132 | muscle structure development (GO:0061061) | 3.31545806 |
| 133 | muscle cell development (GO:0055001) | 3.30754134 |
| 134 | relaxation of muscle (GO:0090075) | 3.29623692 |
| 135 | positive regulation of myotube differentiation (GO:0010831) | 3.28837878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.55456995 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.41358791 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.22293273 |
| 4 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.05370744 |
| 5 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.05370744 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.01434157 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.76052491 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.56791150 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.47543453 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.87430033 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.83422069 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.45018200 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.44487813 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.44093981 |
| 15 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.34056833 |
| 16 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.23124026 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11250954 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09654448 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02501771 |
| 20 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.01120419 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83456892 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80941109 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80202504 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.79670836 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66373450 |
| 26 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66229295 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65205177 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64369695 |
| 29 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.63040879 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55458742 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47621361 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.47439711 |
| 33 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46831556 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40958588 |
| 35 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40778675 |
| 36 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.40500659 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40110944 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38286592 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38285566 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38172459 |
| 41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34970051 |
| 42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.33888490 |
| 43 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32356646 |
| 44 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.31953548 |
| 45 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.29696977 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23015184 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21299154 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20916807 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19851096 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18664963 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17202545 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15530282 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15304797 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15023313 |
| 55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14651583 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13114566 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12913905 |
| 58 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.12788538 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.12675942 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12448739 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11608064 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08953610 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07466728 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06990509 |
| 65 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06768362 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06476735 |
| 67 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04083923 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02522367 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01638489 |
| 70 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.99842962 |
| 71 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98475530 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98401423 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97486291 |
| 74 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96532738 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96347359 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95732952 |
| 77 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94863702 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94637372 |
| 79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94581391 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.94346651 |
| 81 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93638379 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93116667 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93063582 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92309236 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91611985 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91478241 |
| 87 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91369106 |
| 88 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91331481 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90760399 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90614803 |
| 91 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.90436813 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89552539 |
| 93 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89101062 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86986427 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86671645 |
| 96 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85909661 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85783448 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84237731 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83003929 |
| 100 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.82989209 |
| 101 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82558961 |
| 102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82537586 |
| 103 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82466146 |
| 104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82155357 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82091478 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81979155 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81973942 |
| 108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81606415 |
| 109 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81545648 |
| 110 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.79814839 |
| 111 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79311952 |
| 112 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.79210364 |
| 113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79195197 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78883878 |
| 115 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.78592946 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78245036 |
| 117 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78079554 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77689990 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77305894 |
| 120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77179345 |
| 121 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76610483 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76366325 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74217692 |
| 124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73566444 |
| 125 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.73364891 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73073465 |
| 127 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.71782419 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70166971 |
| 129 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.69888930 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.68888772 |
| 131 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68757518 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67797569 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67797569 |
| 134 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.65777080 |
| 135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.65425957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.84295261 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.89101880 |
| 3 | MP0000751_myopathy | 5.44644086 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.88630924 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.36584844 |
| 6 | * MP0003646_muscle_fatigue | 4.24188429 |
| 7 | MP0005330_cardiomyopathy | 3.96254861 |
| 8 | MP0000749_muscle_degeneration | 3.94898506 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.16380194 |
| 10 | * MP0002972_abnormal_cardiac_muscle | 3.05018325 |
| 11 | MP0003137_abnormal_impulse_conducting | 2.93503792 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.89264236 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.86404269 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.70381830 |
| 15 | MP0001544_abnormal_cardiovascular_syste | 2.66902960 |
| 16 | MP0005385_cardiovascular_system_phenoty | 2.66902960 |
| 17 | MP0010630_abnormal_cardiac_muscle | 2.62613807 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.56984166 |
| 19 | MP0004130_abnormal_muscle_cell | 2.49789511 |
| 20 | MP0004484_altered_response_of | 2.45409951 |
| 21 | MP0002269_muscular_atrophy | 2.36117862 |
| 22 | MP0003828_pulmonary_edema | 2.27180184 |
| 23 | * MP0006138_congestive_heart_failure | 2.12157934 |
| 24 | MP0004085_abnormal_heartbeat | 2.12147804 |
| 25 | MP0005369_muscle_phenotype | 2.09596712 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 2.04914898 |
| 27 | MP0000747_muscle_weakness | 2.01597983 |
| 28 | * MP0000759_abnormal_skeletal_muscle | 1.96924100 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.90995317 |
| 30 | MP0004510_myositis | 1.86036400 |
| 31 | MP0004233_abnormal_muscle_weight | 1.71487160 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.65068079 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.58968145 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.55506216 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.49826851 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.42476804 |
| 37 | MP0005670_abnormal_white_adipose | 1.41472817 |
| 38 | MP0000343_altered_response_to | 1.23772571 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.17615409 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.16346643 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.14653942 |
| 42 | MP0003279_aneurysm | 1.13744764 |
| 43 | MP0000266_abnormal_heart_morphology | 1.13678870 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.11415411 |
| 45 | MP0005165_increased_susceptibility_to | 1.10160292 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.07584869 |
| 47 | MP0001661_extended_life_span | 0.98149559 |
| 48 | MP0004270_analgesia | 0.96716293 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 0.91630006 |
| 50 | MP0002108_abnormal_muscle_morphology | 0.91470643 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 0.87171916 |
| 52 | MP0005623_abnormal_meninges_morphology | 0.81602592 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.81323248 |
| 54 | * MP0002128_abnormal_blood_circulation | 0.76821347 |
| 55 | MP0003566_abnormal_cell_adhesion | 0.75734698 |
| 56 | MP0002909_abnormal_adrenal_gland | 0.74611117 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 0.68213184 |
| 58 | MP0000767_abnormal_smooth_muscle | 0.65176324 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 0.64950711 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.63380032 |
| 61 | MP0000733_abnormal_muscle_development | 0.62840319 |
| 62 | * MP0005266_abnormal_metabolism | 0.61288984 |
| 63 | MP0000013_abnormal_adipose_tissue | 0.60587809 |
| 64 | MP0005187_abnormal_penis_morphology | 0.59261707 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 0.57314463 |
| 66 | MP0004043_abnormal_pH_regulation | 0.54376570 |
| 67 | MP0002971_abnormal_brown_adipose | 0.53923030 |
| 68 | MP0005451_abnormal_body_composition | 0.52103009 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.50420424 |
| 70 | MP0005275_abnormal_skin_tensile | 0.49369961 |
| 71 | MP0008569_lethality_at_weaning | 0.49079089 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.47898600 |
| 73 | MP0004147_increased_porphyrin_level | 0.46523833 |
| 74 | MP0001299_abnormal_eye_distance/ | 0.44657807 |
| 75 | MP0004272_abnormal_basement_membrane | 0.43994057 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.43972617 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.43916137 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.41051944 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.40875128 |
| 80 | * MP0002925_abnormal_cardiovascular_devel | 0.40644673 |
| 81 | MP0009840_abnormal_foam_cell | 0.40410809 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37431574 |
| 83 | MP0003879_abnormal_hair_cell | 0.35015980 |
| 84 | MP0005535_abnormal_body_temperature | 0.34272523 |
| 85 | MP0001784_abnormal_fluid_regulation | 0.33270365 |
| 86 | * MP0001614_abnormal_blood_vessel | 0.32012078 |
| 87 | MP0001958_emphysema | 0.31176177 |
| 88 | MP0005083_abnormal_biliary_tract | 0.30378540 |
| 89 | MP0005334_abnormal_fat_pad | 0.29981304 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.29611009 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.29524189 |
| 92 | MP0002822_catalepsy | 0.29419520 |
| 93 | MP0004134_abnormal_chest_morphology | 0.28997105 |
| 94 | * MP0003984_embryonic_growth_retardation | 0.28691533 |
| 95 | MP0005332_abnormal_amino_acid | 0.28343116 |
| 96 | MP0004924_abnormal_behavior | 0.28311073 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.28311073 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.27708030 |
| 99 | * MP0002088_abnormal_embryonic_growth/wei | 0.27255184 |
| 100 | MP0005166_decreased_susceptibility_to | 0.27203451 |
| 101 | MP0005452_abnormal_adipose_tissue | 0.27128278 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.26468598 |
| 103 | * MP0005376_homeostasis/metabolism_phenot | 0.25987002 |
| 104 | MP0009115_abnormal_fat_cell | 0.25166939 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.24117673 |
| 106 | MP0000249_abnormal_blood_vessel | 0.23799596 |
| 107 | MP0004142_abnormal_muscle_tone | 0.23533185 |
| 108 | * MP0003948_abnormal_gas_homeostasis | 0.23452056 |
| 109 | MP0009780_abnormal_chondrocyte_physiolo | 0.23236749 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.23179680 |
| 111 | MP0009672_abnormal_birth_weight | 0.23082019 |
| 112 | MP0003045_fibrosis | 0.22481073 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.22476567 |
| 114 | MP0005423_abnormal_somatic_nervous | 0.22332371 |
| 115 | MP0010030_abnormal_orbit_morphology | 0.21689163 |
| 116 | MP0008874_decreased_physiological_sensi | 0.21653676 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.21464595 |
| 118 | MP0001853_heart_inflammation | 0.21125480 |
| 119 | MP0000579_abnormal_nail_morphology | 0.21122318 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.20918947 |
| 121 | MP0002114_abnormal_axial_skeleton | 0.19632111 |
| 122 | MP0002066_abnormal_motor_capabilities/c | 0.17106450 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.16492497 |
| 124 | MP0001943_abnormal_respiration | 0.15258405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.95192073 |
| 2 | Sudden death (HP:0001699) | 8.27153897 |
| 3 | Ventricular tachycardia (HP:0004756) | 7.16197209 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.62337328 |
| 5 | Muscle fiber splitting (HP:0003555) | 6.09312087 |
| 6 | Atrial fibrillation (HP:0005110) | 6.09178881 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.07388969 |
| 8 | Exercise-induced myalgia (HP:0003738) | 5.85409589 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 5.79100876 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 5.70266027 |
| 11 | Supraventricular tachycardia (HP:0004755) | 5.51780294 |
| 12 | Lipoatrophy (HP:0100578) | 5.48252259 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 5.44252179 |
| 14 | Supraventricular arrhythmia (HP:0005115) | 5.41040498 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 5.32008611 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 5.12045309 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.09880914 |
| 18 | Subaortic stenosis (HP:0001682) | 5.09880914 |
| 19 | Myopathic facies (HP:0002058) | 5.04375858 |
| 20 | Distal arthrogryposis (HP:0005684) | 4.93952329 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.86714751 |
| 22 | Bundle branch block (HP:0011710) | 4.81108689 |
| 23 | Myoglobinuria (HP:0002913) | 4.71256493 |
| 24 | Syncope (HP:0001279) | 4.70449592 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 4.56974688 |
| 26 | Palpitations (HP:0001962) | 4.48700569 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 4.42065271 |
| 28 | Prolonged QT interval (HP:0001657) | 4.31648471 |
| 29 | Increased connective tissue (HP:0009025) | 4.27750888 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 4.18263069 |
| 31 | Round ear (HP:0100830) | 4.11953272 |
| 32 | Heart block (HP:0012722) | 3.96933955 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.93517498 |
| 34 | Atrioventricular block (HP:0001678) | 3.88352610 |
| 35 | Ulnar deviation of the wrist (HP:0003049) | 3.80433563 |
| 36 | Difficulty running (HP:0009046) | 3.78271114 |
| 37 | Abnormal atrioventricular conduction (HP:0005150) | 3.75498281 |
| 38 | Ventricular fibrillation (HP:0001663) | 3.72747531 |
| 39 | Myotonia (HP:0002486) | 3.63340965 |
| 40 | Rhabdomyolysis (HP:0003201) | 3.56552797 |
| 41 | Frequent falls (HP:0002359) | 3.31209835 |
| 42 | Calcaneovalgus deformity (HP:0001848) | 3.29072678 |
| 43 | Difficulty climbing stairs (HP:0003551) | 3.17098551 |
| 44 | Abnormal EKG (HP:0003115) | 3.07936885 |
| 45 | Absent phalangeal crease (HP:0006109) | 2.95964084 |
| 46 | Left ventricular hypertrophy (HP:0001712) | 2.91779998 |
| 47 | Deformed tarsal bones (HP:0008119) | 2.90252959 |
| 48 | Hepatic necrosis (HP:0002605) | 2.80903253 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.79237486 |
| 50 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.78520386 |
| 51 | Testicular atrophy (HP:0000029) | 2.78132129 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.75343712 |
| 53 | Ketoacidosis (HP:0001993) | 2.75285660 |
| 54 | Palmoplantar keratoderma (HP:0000982) | 2.74050157 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.69567654 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.67902085 |
| 57 | Bulbar palsy (HP:0001283) | 2.65199532 |
| 58 | Type 1 muscle fiber predominance (HP:0003803) | 2.62260408 |
| 59 | Areflexia of lower limbs (HP:0002522) | 2.56648592 |
| 60 | Progressive muscle weakness (HP:0003323) | 2.49796604 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49663089 |
| 62 | Malignant hyperthermia (HP:0002047) | 2.48811391 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.47433148 |
| 64 | Neck muscle weakness (HP:0000467) | 2.46633185 |
| 65 | Muscle stiffness (HP:0003552) | 2.46168086 |
| 66 | Abnormal finger flexion creases (HP:0006143) | 2.42806441 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.41114929 |
| 68 | Acute encephalopathy (HP:0006846) | 2.38949667 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.36678729 |
| 70 | Muscle fiber inclusion bodies (HP:0100299) | 2.36370504 |
| 71 | Weak cry (HP:0001612) | 2.36018524 |
| 72 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.32992115 |
| 73 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.28977155 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.26008309 |
| 75 | Progressive macrocephaly (HP:0004481) | 2.25953113 |
| 76 | Mitochondrial inheritance (HP:0001427) | 2.25485275 |
| 77 | Cerebral edema (HP:0002181) | 2.22761752 |
| 78 | Conjunctival hamartoma (HP:0100780) | 2.22757057 |
| 79 | Abnormality of the foot musculature (HP:0001436) | 2.22702791 |
| 80 | Ragged-red muscle fibers (HP:0003200) | 2.22294814 |
| 81 | Slender build (HP:0001533) | 2.21610293 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.21558158 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21558158 |
| 84 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15363920 |
| 85 | Foot dorsiflexor weakness (HP:0009027) | 2.11209380 |
| 86 | Increased CSF lactate (HP:0002490) | 2.09641020 |
| 87 | Dysmetric saccades (HP:0000641) | 2.08541890 |
| 88 | Sudden cardiac death (HP:0001645) | 2.07661127 |
| 89 | Spinal rigidity (HP:0003306) | 2.07231423 |
| 90 | Large for gestational age (HP:0001520) | 2.06947770 |
| 91 | Ketosis (HP:0001946) | 2.04861195 |
| 92 | Waddling gait (HP:0002515) | 2.04654868 |
| 93 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04264556 |
| 94 | Congestive heart failure (HP:0001635) | 2.03489261 |
| 95 | EMG: neuropathic changes (HP:0003445) | 2.03220964 |
| 96 | Rimmed vacuoles (HP:0003805) | 2.02991043 |
| 97 | Increased intramyocellular lipid droplets (HP:0012240) | 2.02891963 |
| 98 | Hip contracture (HP:0003273) | 2.01086808 |
| 99 | Muscular dystrophy (HP:0003560) | 2.00987802 |
| 100 | Exercise intolerance (HP:0003546) | 2.00032941 |
| 101 | Hypoplastic ischia (HP:0003175) | 1.99872922 |
| 102 | Pheochromocytoma (HP:0002666) | 1.98692336 |
| 103 | Gowers sign (HP:0003391) | 1.97373962 |
| 104 | Fetal akinesia sequence (HP:0001989) | 1.95859659 |
| 105 | Respiratory failure (HP:0002878) | 1.94580984 |
| 106 | Lactic acidosis (HP:0003128) | 1.93594608 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92981315 |
| 108 | Hyperkalemia (HP:0002153) | 1.92441767 |
| 109 | Fatigable weakness (HP:0003473) | 1.91841883 |
| 110 | Abnormality of the neuromuscular junction (HP:0003398) | 1.91841883 |
| 111 | Hamartoma of the eye (HP:0010568) | 1.90887364 |
| 112 | Facial diplegia (HP:0001349) | 1.88434581 |
| 113 | Generalized muscle weakness (HP:0003324) | 1.84920874 |
| 114 | Scapular winging (HP:0003691) | 1.84480612 |
| 115 | Neoplasm of head and neck (HP:0012288) | 1.84204032 |
| 116 | Esophageal neoplasm (HP:0100751) | 1.84204032 |
| 117 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.83796016 |
| 118 | Abnormality of the calcaneus (HP:0008364) | 1.82439648 |
| 119 | Broad metatarsal (HP:0001783) | 1.78378795 |
| 120 | Neuroendocrine neoplasm (HP:0100634) | 1.75842287 |
| 121 | Lower limb amyotrophy (HP:0007210) | 1.75520492 |
| 122 | Abnormality of the ischium (HP:0003174) | 1.73073388 |
| 123 | Proximal amyotrophy (HP:0007126) | 1.72348010 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 1.68914833 |
| 125 | Hyperalaninemia (HP:0003348) | 1.68914833 |
| 126 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68914833 |
| 127 | Limb-girdle muscle weakness (HP:0003325) | 1.61334524 |
| 128 | Steppage gait (HP:0003376) | 1.56053755 |
| 129 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.48248744 |
| 130 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.48248744 |
| 131 | Shoulder girdle muscle weakness (HP:0003547) | 1.38394920 |
| 132 | Pelvic girdle muscle weakness (HP:0003749) | 1.38135790 |
| 133 | Limited hip movement (HP:0008800) | 1.33660515 |
| 134 | Nonprogressive disorder (HP:0003680) | 1.33192972 |
| 135 | Paralysis (HP:0003470) | 1.29990745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.39995454 |
| 2 | PHKG1 | 4.21947217 |
| 3 | PHKG2 | 4.21947217 |
| 4 | LMTK2 | 4.19129672 |
| 5 | OBSCN | 4.09754112 |
| 6 | MYLK | 3.66446898 |
| 7 | PDK4 | 3.25732548 |
| 8 | PDK3 | 3.25732548 |
| 9 | DMPK | 3.11648724 |
| 10 | PKN2 | 2.82417844 |
| 11 | TRIB3 | 2.81810433 |
| 12 | MUSK | 2.65229812 |
| 13 | BCKDK | 2.55938045 |
| 14 | PIK3CA | 2.33759516 |
| 15 | NEK1 | 2.12681181 |
| 16 | PINK1 | 2.08579088 |
| 17 | TIE1 | 2.07372489 |
| 18 | PDK2 | 1.96102523 |
| 19 | PAK3 | 1.51121384 |
| 20 | STK24 | 1.42859479 |
| 21 | PRKD1 | 1.41108182 |
| 22 | CAMK2D | 1.35104624 |
| 23 | GRK7 | 1.29482907 |
| 24 | MARK1 | 1.12910475 |
| 25 | ILK | 1.06313904 |
| 26 | LIMK1 | 1.05542692 |
| 27 | MAPKAPK3 | 1.04530634 |
| 28 | ROCK1 | 1.04133814 |
| 29 | STK4 | 1.03979901 |
| 30 | MAPK12 | 1.03336267 |
| 31 | MAP3K7 | 1.02073597 |
| 32 | CDC42BPA | 1.01520541 |
| 33 | RIPK1 | 1.00673619 |
| 34 | MAP2K4 | 0.95898762 |
| 35 | MAP3K5 | 0.91571388 |
| 36 | WNK4 | 0.89532249 |
| 37 | PKN1 | 0.89485652 |
| 38 | EEF2K | 0.89378579 |
| 39 | PRKAA1 | 0.86725206 |
| 40 | MAP2K3 | 0.85739701 |
| 41 | PDGFRA | 0.83590792 |
| 42 | DAPK3 | 0.81236186 |
| 43 | PRKAA2 | 0.80011207 |
| 44 | EPHB1 | 0.76360610 |
| 45 | TRPM7 | 0.73730643 |
| 46 | INSRR | 0.73696015 |
| 47 | FLT3 | 0.70235034 |
| 48 | ROCK2 | 0.70178927 |
| 49 | CAMK4 | 0.69455380 |
| 50 | MOS | 0.68371713 |
| 51 | MAP2K6 | 0.68045014 |
| 52 | RPS6KC1 | 0.68030156 |
| 53 | RPS6KL1 | 0.68030156 |
| 54 | STK38 | 0.67888707 |
| 55 | MAP3K3 | 0.67258918 |
| 56 | STK38L | 0.66401207 |
| 57 | KDR | 0.62316757 |
| 58 | DYRK1B | 0.62135536 |
| 59 | TGFBR2 | 0.61697266 |
| 60 | ZAK | 0.61324882 |
| 61 | CCNB1 | 0.61269957 |
| 62 | CAMK2A | 0.59620440 |
| 63 | ICK | 0.59368167 |
| 64 | RPS6KA6 | 0.59166360 |
| 65 | ERBB3 | 0.57385170 |
| 66 | MAPK4 | 0.56016705 |
| 67 | MAP3K6 | 0.54667580 |
| 68 | PRKACB | 0.52416572 |
| 69 | WNK1 | 0.51489303 |
| 70 | MAP2K1 | 0.50802056 |
| 71 | NME1 | 0.50377254 |
| 72 | CAMK2B | 0.49927032 |
| 73 | PTK2B | 0.48816944 |
| 74 | PRKCE | 0.48030695 |
| 75 | SIK1 | 0.43985747 |
| 76 | KSR2 | 0.42385233 |
| 77 | CAMK1 | 0.41900795 |
| 78 | PRKACG | 0.40403537 |
| 79 | PDPK1 | 0.39773200 |
| 80 | PRKACA | 0.39538397 |
| 81 | MAP3K13 | 0.39197256 |
| 82 | PTK6 | 0.36655663 |
| 83 | PRKCH | 0.36507720 |
| 84 | AKT2 | 0.35213215 |
| 85 | CAMK2G | 0.33804550 |
| 86 | PDK1 | 0.29142440 |
| 87 | RPS6KA1 | 0.28610253 |
| 88 | TBK1 | 0.27777660 |
| 89 | SGK2 | 0.27173674 |
| 90 | PRPF4B | 0.26679066 |
| 91 | EPHB2 | 0.26488583 |
| 92 | MTOR | 0.26448774 |
| 93 | TAOK1 | 0.26386484 |
| 94 | PRKD3 | 0.26324597 |
| 95 | FER | 0.26021566 |
| 96 | NME2 | 0.25395656 |
| 97 | TAOK2 | 0.24723036 |
| 98 | NEK9 | 0.23997587 |
| 99 | FGFR4 | 0.23165231 |
| 100 | LATS2 | 0.22829698 |
| 101 | JAK1 | 0.22503573 |
| 102 | PRKG2 | 0.21948741 |
| 103 | SGK3 | 0.21762271 |
| 104 | MAPK10 | 0.21536482 |
| 105 | STK39 | 0.20924790 |
| 106 | RPS6KA2 | 0.19444770 |
| 107 | RET | 0.18906655 |
| 108 | EPHA3 | 0.18540393 |
| 109 | PRKG1 | 0.17244651 |
| 110 | RPS6KB2 | 0.17092555 |
| 111 | RPS6KA3 | 0.16311490 |
| 112 | ZAP70 | 0.16037603 |
| 113 | SGK1 | 0.16002640 |
| 114 | MARK2 | 0.15185519 |
| 115 | MAP3K1 | 0.14317808 |
| 116 | LRRK2 | 0.13983428 |
| 117 | RPS6KB1 | 0.13838067 |
| 118 | MAPK11 | 0.13559236 |
| 119 | PIK3CG | 0.13230478 |
| 120 | PAK6 | 0.13035341 |
| 121 | ARAF | 0.12446612 |
| 122 | MAPK7 | 0.12271316 |
| 123 | PDGFRB | 0.12225120 |
| 124 | LATS1 | 0.11993316 |
| 125 | MARK3 | 0.11274887 |
| 126 | MAP3K11 | 0.11017021 |
| 127 | SGK223 | 0.10125801 |
| 128 | SGK494 | 0.10125801 |
| 129 | NLK | 0.08944295 |
| 130 | STK11 | 0.08800531 |
| 131 | RAF1 | 0.05467795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.71164143 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.36184340 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.31497357 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.93477313 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.81554380 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.58804244 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.18028206 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09279235 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01773852 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.82827725 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.49204862 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.40127296 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31162903 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21967323 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.14764953 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.12074493 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.94859522 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.88948227 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78008408 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73387638 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46351874 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42236180 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41716127 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21869327 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14782553 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14691152 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09886830 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09153343 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.07090033 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02964774 |
| 31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02143146 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99046305 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95279812 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89982468 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88778091 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88357953 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 0.84875171 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75898996 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72589822 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72566648 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72184917 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 0.71661186 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71411510 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69200769 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68725934 |
| 46 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67788484 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64297848 |
| 48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63316799 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57943926 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57762875 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57063773 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56737583 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55077821 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54480662 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.53483867 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53168535 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52192544 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51359019 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49564749 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.48302525 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48259876 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.44190700 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44058934 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42162554 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42131665 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41127733 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40425677 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40072690 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.39149143 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.39110657 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37182713 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.35366502 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.32098880 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31814785 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28634897 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28258718 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.23845636 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23752278 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.23380082 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23284400 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.22469198 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22054915 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.21949823 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21400535 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20560735 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20013419 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19919612 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18718336 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18686548 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18359987 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.15900711 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.15596793 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15550856 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15549422 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.14937377 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14888616 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.14692949 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14462441 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.14155649 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.12629381 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12279156 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.11469191 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.09653438 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09624218 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08497236 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.08142780 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07269841 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.07163386 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.07031833 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06370716 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.05528269 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04795672 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.04021021 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.03248604 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.01769547 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.01456928 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.00405017 |

